Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030 2023-07-28 12:00
Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development 2023-07-28 11:56
61.6 percent of Young Thai Women Put off by Pap Smears: BGI Genomics Cervical Cancer Survey 2023-07-28 08:37
Clarivate Enhances Patient Data Intelligence Solution with Addition of German Hospital Prescribing Insights 2023-07-27 15:00
Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress 2023-07-27 10:57
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China 2023-07-27 08:10
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023 2023-07-27 05:00
Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development 2023-07-27 04:00
World's first*1 report: A potential effectiveness of Plasmacluster Technology that may induce brain activation 2023-07-26 14:15
RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal 2023-07-25 16:00
Clinical Results of ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection Presented at the 12th IAS Conference on HIV Science 2023-07-25 08:10
Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation 2023-07-21 23:44
Saphnelo now available in Malaysia as an add-on treatment for adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE) 2023-07-21 10:00
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study 2023-07-21 08:00
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs 2023-07-20 19:15
Gannex Announces the Completion of Patient Enrollment for Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis 2023-07-20 08:10
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow 2023-07-19 16:14
The International Conference on Pharmaceutical Innovation and Development 2023 Kicked off in Yantai 2023-07-19 16:09
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet 2023-07-19 08:52
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib 2023-07-19 05:00
1 27 28 29 30 31 230